Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Shang Wu

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Chest|February 7, 2018
ResponseI-Hsuan Wu, Jin-Shang Wu
Journal of Clinical Medicine|September 28, 2019
Decreased Associated Risk of Gout in Diabetes Patients with Uric Acid UrolithiasisChan Jung Liu, Jin Shang Wu, Ho Shang Huang
Diabetes, Obesity & Metabolism|September 7, 2018
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort studyShihchen Kuo, Chun-Ting Yang, Jin-Shang Wu, et al.
Journal of Diabetes|April 11, 2016
Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from TaiwanHuang-Tz Ou, Kai-Cheng Chang, Ya-Ming Liu, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Comparative cost-effectiveness of metformin-based dual therapies associated with risk of cardiovascular diseases among Chinese patients with type 2 diabetes: Evidence from a population-based national cohort in TaiwanHuang-Tz Ou, Yen-Ting Chen, Ya-Ming Liu, et al.
British Journal of Clinical Pharmacology|January 22, 2017
Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetesHuang-Tz Ou, Kai-Cheng Chang, Chung-Yi Li, et al.
Cardiovascular Diabetology|March 3, 2016
Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal studyHuang-Tz Ou, Kai-Cheng Chang, Chung-Yi Li, et al.
Neuroscience Letters|December 29, 2007
Impaired regulation function in cardiovascular neurons of nucleus tractus solitarii in streptozotocin-induced diabetic ratsHsin-Yung Chen, Jin-Shang Wu, Jia-Jin Jason Chen, et al.
Diabetes Care|May 24, 2020
Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-upHsuan-Ying Chen, Shihchen Kuo, Pei-Fang Su, et al.
BMJ Open|June 23, 2017
Incidence of diabetes-related complications in Chinese patients with type 1 diabetes: a population-based longitudinal cohort study in TaiwanHuang-Tz Ou, Tsung-Ying Lee, Chung-Yi Li, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Chest|February 7, 2018
ResponseI-Hsuan Wu, Jin-Shang Wu
Journal of Clinical Medicine|September 28, 2019
Decreased Associated Risk of Gout in Diabetes Patients with Uric Acid UrolithiasisChan Jung Liu, Jin Shang Wu, Ho Shang Huang
Diabetes, Obesity & Metabolism|September 7, 2018
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort studyShihchen Kuo, Chun-Ting Yang, Jin-Shang Wu, et al.
Journal of Diabetes|April 11, 2016
Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from TaiwanHuang-Tz Ou, Kai-Cheng Chang, Ya-Ming Liu, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Comparative cost-effectiveness of metformin-based dual therapies associated with risk of cardiovascular diseases among Chinese patients with type 2 diabetes: Evidence from a population-based national cohort in TaiwanHuang-Tz Ou, Yen-Ting Chen, Ya-Ming Liu, et al.
British Journal of Clinical Pharmacology|January 22, 2017
Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetesHuang-Tz Ou, Kai-Cheng Chang, Chung-Yi Li, et al.
Cardiovascular Diabetology|March 3, 2016
Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal studyHuang-Tz Ou, Kai-Cheng Chang, Chung-Yi Li, et al.
Neuroscience Letters|December 29, 2007
Impaired regulation function in cardiovascular neurons of nucleus tractus solitarii in streptozotocin-induced diabetic ratsHsin-Yung Chen, Jin-Shang Wu, Jia-Jin Jason Chen, et al.
Diabetes Care|May 24, 2020
Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-upHsuan-Ying Chen, Shihchen Kuo, Pei-Fang Su, et al.
BMJ Open|June 23, 2017
Incidence of diabetes-related complications in Chinese patients with type 1 diabetes: a population-based longitudinal cohort study in TaiwanHuang-Tz Ou, Tsung-Ying Lee, Chung-Yi Li, et al.
Pageof 12